AnalystsKyle MiksonKyle Mikson's Stock Forecasts
AnalystsKyle Mikson
Analyst Ranking
Bottom 1%
#4034 out of 4035 analysts
Average Return
-60.76%
Win Rate
0%0 out of 16
Risk vs Reward
Poor
Good
Kyle Mikson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
No Ratings AvailableKyle Mikson doesn't have any winning ratings in our database | |||||
Kyle Mikson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Quanterix CorpQTRX | 2 | Hold | $12.00 | +41.68% | Downgrades | a month ago |
Somalogic IncSLGC | 2 | Strong Buy | $15.00 | +400.00% | Maintains | 4 months ago |
Nanostring Technologies IncNSTG | 2 | Strong Buy | $37.00 | +184.40% | Maintains | 5 months ago |
Castle Biosciences IncCSTL | 1 | Strong Buy | $80.00 | +224.54% | Maintains | 6 months ago |
Lucid Diagnostics IncLUCD | 2 | Strong Buy | $12.00 | +614.29% | Maintains | 6 months ago |
Pacific Biosciences Of California IncPACB | 2 | Strong Buy | $40.00 | +659.01% | Maintains | 7 months ago |
Quantum Si IncQSI | 1 | Strong Buy | $13.00 | +390.57% | Initiates Coverage On | a year ago |
Exact Sciences CorpEXAS | 1 | Strong Buy | $160.00 | N/A | Maintains | a year ago |
Pavmed IncPAVM | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Volitionrx LtdVNRX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Icad IncICAD | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 2 years ago |
Aspira Women's Health IncAWH | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.